Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12–18 months in Shanghai, China: a cross-sectional study by Hu, Jiayu et al.
RESEARCH ARTICLE Open Access
Streptococcus pneumoniae and Haemophilus
influenzae type b carriage in Chinese
children aged 12–18 months in Shanghai,
China: a cross-sectional study
Jiayu Hu1†, Xiaodong Sun1†, Zhuoying Huang1†, Abram L. Wagner2, Bradley Carlson2, Jianping Yang1,
Suwen Tang1, Yunyi Li1, Matthew L. Boulton2* and Zhengan Yuan1*
Abstract
Background: The bacteria Streptococcus pneumoniae (pneumococcus) and Haemophilus influenzae type b (Hib) are
leading causes of childhood pneumonia and meningitis and are major contributors to worldwide mortality in
children younger than 5 years of age. Asymptomatic nasopharyngeal carriage of pneumococcus and Hib was
determined for healthy children in Shanghai in 2009.
Methods: Children from 5 immunization clinics were enrolled in this study. Specimens from the nasopharynx were
collected and cultured in Columbia and chocolate agar to identify pneumococcal and Hib carriage. Pneumococcal
specimens were serotyped with the Neufeld test, and antibiotic resistance for pneumococcal and Hib specimens
used the E-test method. Significance of risk factors for carriage was assessed through chi-square tests.
Results: Among 614 children, 16.6 % had pneumococcal carriage and 8.0 % Hib carriage. The predominant
serotype of pneumococcus that was isolated was 19 F (52.9 %); serotype coverage was 68.6 % for both 7-valent
pneumococcal conjugate vaccine (PCV) and PCV-10, and 82.3 % for PCV-13. Household residency and father’s
education were both significantly related to pneumococcal and Hib carriage. The majority of S. pneumoniae isolates
were sensitive to most antimicrobials but there were high levels of resistance to azithromycin (51.0 %) and
erythromycin (51.0 %). Haemophilus influenzae isolates were sensitive to almost all antimicrobials tested although
12.2 % of isolates were resistant to ampicillin.
Conclusions: The pneumococcal and Hib vaccines require payment, and the children with the highest burden of
disease may not be receiving these vaccines. Moreover, the presence of high antibiotic susceptibility towards
pneumococcus, and to a lesser extent towards Hib, underscores the need for preventive protection against these
diseases. Public funding of pneumococcal and Hib vaccines would be one mechanism to increase uptake of these
vaccines.
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Background
The bacteria Streptococcus pneumoniae (pneumococcus)
and Haemophilus influenzae type b (Hib) are leading
causes of childhood pneumonia and meningitis and are
major contributors to worldwide mortality in children
younger than 5 years of age. In 2011, an estimated
411,000 deaths occurred worldwide due to pneumococ-
cal pneumonia and 197,000 due to Hib pneumonia [1].
In China, it is estimated that there are 261,000 cases and
11,000 deaths each year in children under 5 years of age
due to pneumococcal pneumonia and meningitis [2], and
19,000 childhood deaths result from Hib infection [3].
Pneumococcus and Hib colonize the upper airways.
Asymptomatic carriers can still transmit to other indi-
viduals, with disease resulting if the pathogens descend
the airway into the lower respiratory tract [4, 5]. Over 90
different serotypes of pneumococcus have been found,
and vaccinations need to strike a reasonable balance be-
tween the financial cost against the value of including
more serotypes known to cause disease [6]. In contrast
to the serotypic diversity with pneumococcus, Hib is a
much more predominant cause of disease than non-type
b H. influenzae [7].
The Hib conjugate vaccine has been available since
1987 in the US [7] and 2000 in China [8], and a
pneumococcal conjugate vaccine (PCV) was licensed in
the US in 2000 [9] and introduced to China in 2008
[10], although it was taken off the market in China in
2014 [11]. Neither the Hib vaccine nor PCV are included
on the publically-funded Expanded Program on
Immunization (EPI) in China, but they are available at
immunization clinics for a fee. The Hib vaccine costs
$13–$17 whereas PCV is much more expensive ($127)
[10]. As a result coverage of Hib vaccine is much higher
than PCV (50.9 % versus 11.4 % in Shanghai); moreover,
although infants as young as 6 weeks are eligible for Hib
vaccine and PCV administration, vaccination is typically
delayed until after 1 year of age. Coverage at 12 months
is around 20 % for Hib vaccine and <5 % for PCV and at
24 months, coverage is approximately 40 % for Hib vac-
cine and 5 % for PCV [12].
The first PCV protected against 7 serotypes of
pneumococcus (PCV-7), but more recently, 10-valent
(PCV-10) and 13-valent (PCV-13) vaccines have been li-
censed [6], and a 15-valent vaccine (PCV-15) is under
development [13]. The World Health Organization
(WHO) recommends that countries choose a PCV de-
pending on the distribution of serotypes within their
population, along with vaccine supply and cost-
effectiveness considerations [6]. Two studies in China
have previously evaluated the coverage between PCVs
and serotypes in the population. A study of clinical iso-
lates from 8 cities in China during 2005 and 2006 found
coverage of PCV-7 was 62.6 %, PCV-10 was 64.8 %, and
PCV-13 was 79.6 % [14]. Similarly, a study of clinical
isolates from 2006 to 2008 found coverage of 60.3, 66.7
and 87.8 % for the 3 vaccines, respectively [15]. Because
the distribution of pneumococcal serotypes may vary
geographically, however, these findings may not be rep-
resentative of potential coverage from vaccines in all
areas.
Few studies have been published from China in the
English literature looking at Hib and pneumococcal car-
riage. This information is important for modeling the
burden of disease and underscoring the importance of
vaccination, particularly in a country with low coverage
of Hib and pneumococcal vaccines but with widespread
resistance to antibiotics [16, 17]. In this study, we calcu-
late the prevalence of nasopharyngeal carriage of Hib
and pneumococcus (including specific pneumococcal se-
rotypes), describe the prevalence of antimicrobial resist-
ance in children with carriage, and examine risk factors
for nasopharyngeal colonization with pneumococcus or
Hib.
Methods
In 2009, April and May for spring, October and Novem-
ber for autumn, healthy children aged 12–18 months
were recruited from a total of 5 immunization clinics in
Shanghai. We purposely sampled in both the spring and
autumn in order to determine if there was a seasonal
fluctuation in carriage (although this has not been borne
out in previous studies in the UK [18] or Italy [19]).
These clinics purposefully selected from 3 districts
(Huangpu, Xuhui, and Pudong) to represent different
areas of the city. For 1 or 2 days, research staff from the
municipal Centers for Disease Control and Prevention
(CDC) and district CDCs attended these clinics, and en-
rolled children between 12 and 18 months who attended
the clinic on those days. Children were excluded for the
following reasons: 1) antibiotic use within 15 days of en-
rollment; 2) congenital anomalies of the nasopharynx; 3)
existence of a long-term infectious disease (such as
chronic otitis media, or chronic sinusitis); 4) previous
immunization for pneumococcal disease; 5) coagolopa-
thy; or 6) body temperature over 38 °C at time of
enrollment.
Parents of the children were asked about their resi-
dency status (local or Shanghai residency vs non-local
residency), their household monthly income, daycare at-
tendance, household size, number of children, highest
educational level attainment of father and mother, smok-
ing in the household,, if child was breastfed, child history
of serious disease, and number of doses of Hib vaccine
the child had received.
Research staff obtained a nasopharyngeal sample using
one infant-sized calcium alginate swab (Thermo Fisher
Scientific, Hampton, NH, USA) for each child. These
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specimens were streaked on Columbia agar and choc-
olate agar immediately upon collection, then transported
in 12 h to the Shanghai Municipal CDC for culturing
and preliminary pathogen identification. The swabs were
streaked directly onto the plates. Positive isolates were
stored at −70 °C, then transported to a centralized la-
boratory in Beijing for pathogen confirmation, pneumo-
coccal serotyping, and antibiotic resistance testing. The
site of specimen collection (nasopharynx), swab material
(calcium alginate fiber), storage temperature (−70 °C),
and choice of agar (5 % sheep blood) followed standard
methods [20].
Isolate confirmation
The specimens streaked on the Columbia and chocolate
agar were incubated at 37 °C in 5 % CO2-enriched at-
mosphere for 24–48 h. Identification of pneumococcal
colonies was based on the following conventional micro-
biological methods: colony morphology, growth on
Columbia agar, susceptibility to optochin, and bile solu-
bility. Colony morphology, growth on chocolate agar,
and the X + V factor were requirements for identification
of H. influenzae colonies. For both pneumococcus and
Hib, a diameter in the inhibition zone >7 mm was re-
corded as a positive result. S. pneumoniae isolates were
serotyped by the Neufeld (Quellung) reaction, by inocu-
lating a broth with culture from the agar plate, and then
mixing a selection from the broth with antiserum and
determining if a reaction occurred.
Antimicrobial susceptibility tests
Minimum inhibitory concentrations (MICs) of anti-
microbial agents were determined by E-test method.
The pneumococcal and Hib isolates were tested for sus-
ceptibility to azithromycin, cefuroxime, ceftriaxone, levo-
floxacin, and moxifloxacin. Pneumococcal isolates were
additionally tested for resistance to amoxicillin/clavula-
nic acid, erythromycin, and penicillin. H. influenzae iso-
lates were tested for susceptibility to ampicillin.
Standard references were included for quality control.
Statistical analysis
Descriptive statistics were used to illustrate the preva-
lence of Hib and pneumococcal carriage, antibiotic re-
sistance, S. pneumoniae serotypes, season of enrollment,
and other demographic characteristics of the enrolled
children. For bivariate analyses, the Pearson chi-square
test was used to test the association between dichotom-
ous demographic factors and 1) carriage of S. pneumo-
niae and 2) carriage of Hib. The Cochran-Armitage
Trend Test was used to compute P-values for ordinal
variables (age of child, age of mother at childbirth, urba-
nicity, household income, size of house, mother’s educa-
tion, father’s education, feeding pattern, and Hib vaccine
history). Exact tests were used if any cell counts were
≤5. Correction for multiple testing was done through
the sequential Holm-Bonferroni Method.
For the multivariable analysis, the explanatory vari-
ables input into the logistic regression model were either
related due to (1) a priori considerations (age of child),
(2) selection criteria (season, urbanicity), or (3) variables
found to be significant (P-value <0.05) in the bivariate
analysis. Mother’s education level and father’s education
level were not placed in the same model together be-
cause of concerns about multicollinearity. Analyses were
performed in SAS version 9.3 (SAS Institute, Inc, Cary,
NC, USA). P-value correction for multiple testing was
computed in R version 3.0.3 (R Foundation for Statistical
Computing, Vienna, Austria).
Results
In this study, 6 parents refused to participate, leaving a
total of 614 children aged 12 to 18 months enrolled: 308
in the spring and 306 in the autumn. Table 1 highlights
the demographic and carrier state risk factors; 338
were male, and 160 were local residents, whereas 454
were non-local children whose family had relocated
to Shanghai from another province. Children with
PCV already administered were excluded from partici-
pating in the study, but 80.7 % of children had re-
ceived at least one dose of Hib vaccine. No child in
the study attended a daycare.
Overall, 137 (22.3 %) of participants were carriers of
one or more pathogen. More children were carriers of
pneumococcus (16.6 %) than Hib (8.0 %). Household
residency and father’s education were the two significant
risk factors for pneumococcal carriage: more non-locals
(20.0 %) than locals (6.9 %) were carriers (P = 0.0009),
and children having a father with less education were
more likely to be carriers (P = 0.0406). For Hib carriage,
in addition to household residency and father’s educa-
tion, urbanicity, household income, size of house, and
mother’s education were significant risk factors. Urban
dwellers had lower carriage (5.9 %) than those in subur-
ban (9.5 %) or rural areas (18.2 %) (P = 0.0077), and hav-
ing greater income and a larger house were protective
against Hib carriage. Hib vaccination was not associated
Hib carriage status (P = 0.3392).
The most common pneumococcal serotype was 19 F,
which was in 54 children. In descending order of preva-
lence, the other isolated serotypes present in the sample
were 19A (n = 8), 6A (n = 6), 6B (n = 5), 6A/6B cross-
reactive (n = 5), 23 F (n = 4), 15 (n = 4), 14 (n = 2), and 1
each for 17 and 22Twelve specimens were untypeable.
The prevalences we found correspond to a coverage of
68.6 % (70) for PCV-7 and PCV-10, 82.3 % (84) for
PCV-13, and 83.3 % (85) for PCV-15.
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Table 1 Prevalence of nasopharyngeal carriage of pneumococcus and Haemophilus influenzae type b (Hib) and demographic and
medical correlates among children in Shanghai, 2009
Count Pneumococcal carriage (%) P-valuea Hib carriage (%) P-valuea
Overall 614 102 (16.6 %) 49 (8.0 %)
Season of enrollment 0.0780 1.0000
Autumn 306 38 (12.4 %) 23 (7.5 %)
Spring 308 64 (20.8 %) 26 (8.4 %)
Sex 1.0000 1.0000
Male 338 60 (17.8 %) 30 (8.9 %)
Female 276 42 (15.2 %) 19 (6.9 %)
Age of child 0.1530 1.0000
12 months 170 35 (20.6 %) 14 (8.2 %)
13–14 months 184 35 (19.0 %) 16 (8.7 %)
15–16 months 158 20 (12.7 %) 12 (7.6 %)
17–18 months 102 12 (11.8 %) 7 (6.9 %)
Age of mother at childbirth 0.3984 1.0000
18–24 years 179 35 (19.6 %) 18 (10.1 %)
25–29 years 257 44 (17.1 %) 18 (7.0 %)
30–34 years 123 18 (14.6 %) 9 (7.3 %)
35–44 years 55 5 (9.1 %) 4 (7.3 %)
Household residency 0.0009 0.0008
Local 160 11 (6.9 %) 2 (1.3 %)
Non-local 454 91 (20.0 %) 47 (10.4 %)
Urbanicity 0.1530 0.0077
Urban 422 62 (14.7 %) 25 (5.9 %)
Suburban 126 22 (17.5 %) 12 (9.5 %)
Rural 66 18 (27.3 %) 12 (18.2 %)
Household income 0.1166 0.0490
<2000 yuan ($292) 232 47 (20.3 %) 26 (11.2 %)
2000–4999 yuan ($292–$730) 286 47 (16.4 %) 21 (7.3 %)
≥5000 yuan ($731) 96 8 (8.3 %) 2 (2.1 %)
Size of house 0.2163 0.0008
<18 m2 145 32 (22.1 %) 17 (11.7 %)
18–29 m2 120 20 (16.7 %) 19 (15.8 %)
30–69 m2 156 25 (16.0 %) 8 (5.1 %)
≥70 m2 193 25 (13.0 %) 5 (2.6 %)
Siblings 0.1530 0.0999
No 407 57 (14.0 %) 24 (5.9 %)
Yes 207 45 (21.7 %) 25 (12.1 %)
Mother’s education 0.0650 0.0008
Primary school or less 73 18 (24.7 %) 9 (12.3 %)
Junior high 286 54 (18.9 %) 32 (11.2 %)
High school/vocational 134 16 (11.9 %) 8 (6.0 %)
College or more 121 14 (11.6 %) 0 (0.0 %)
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Table 2 shows the frequency of antimicrobial resist-
ance for each pathogen. All 102 pneumococcal isolates
were sensitive to levofloxacin and moxifloxacin. Highest
levels of resistance were to azithromycin (51.0 %) and
erythromycin (51.0 %). Most Hib isolates were sensitive
to all antibiotics, except 12.2 % were resistant to
ampicillin.
Results of a multivariable analysis are shown in
Table 3. Pneumococcal carriage was significantly
lower in the spring compared to autumn (odds ratio
(OR) = 0.46, 95 % confidence interval (CI) = 0.27,
0.78). Locals had 0.30 times the odds of pneumococ-
cal carriage compared to non-locals (95 % CI = 0.13,
0.69). No significant predictors of Hib carriage were
found; a more parsimonious model of Hib carriage,
only including the covariates from the pneumococcal
carriage model, also revealed no statistically signifi-
cant predictors (results not shown).
Table 1 Prevalence of nasopharyngeal carriage of pneumococcus and Haemophilus influenzae type b (Hib) and demographic and
medical correlates among children in Shanghai, 2009 (Continued)
Father’s education 0.0406 0.0003
Primary school or less 23 4 (17.4 %) 4 (17.4 %)
Junior high 299 65 (21.7 %) 34 (11.4 %)
High school/vocational 135 16 (11.9 %) 10 (7.4 %)
College or more 157 17 (10.8 %) 1 (0.6 %)
Smoking in home 1.0000 1.0000
No 288 47 (16.3 %) 27 (9.4 %)
Yes 326 55 (16.9 %) 22 (6.7 %)
Feeding pattern (first 6 months) 0.8612 0.3392
Exclusive breastfeeding 317 58 (18.3 %) 35 (11.0 %)
Breastfeeding and formula 207 32 (15.5 %) 7 (3.4 %)
Only formula 90 12 (13.3 %) 7 (7.8 %)
Any history of disease 0.6870 0.8154
No 123 26 (21.1 %) 14 (11.4 %)
Yes 491 76 (15.5 %) 35 (7.1 %)
Hib vaccine history 1.0000 0.3392
None 71 14 (19.7 %) 9 (12.7 %)
1 dose 146 22 (15.1 %) 14 (9.6 %)
2 doses 148 24 (16.2 %) 12 (8.1 %)
3 doses 182 31 (17.0 %) 10 (5.5 %)
4 doses 67 11 (16.4 %) 4 (6.0 %)
aFrom chi-square test, except for age of child, age of mother at childbirth, urbanicity, household income, size of house, mother’s education, father’s education,
feeding pattern, and Hib vaccine history, which were from Cochran-Armitage Trend Test. Exact tests were used if cell counts were ≤5. P-values were corrected for
multiple testing through the sequential Holm-Bonferroni Method
Table 2 Antibiotic Resistance among S. pneumoniae, and H. Influenzae type b isolates in 614 Shanghai children, 2009
Antibiotic S. pneumoniae (n = 102) H. influenzae type b (n = 49)
Sensitive Intermediary Resistant Sensitive Intermediary Resistant
Amoxicillin/Clavulanic Acid 96 (94.1 %) 5 (4.9 %) 1 (1.0 %) – – –
Ampicillin – – – 43 (87.8 %) 0 6 (12.2 %)
Azithromycin 50 (49.0 %) 0 52 (51.0 %) 49 (100.0 %) 0 0
Cefuroxime 82 (80.4 %) 4 (3.9 %) 16 (15.7 %) 49 (100.0 %) 0 0
Ceftriaxone 102 (96.1 %) 3 (2.9 %) 1 (1.0 %) 49 (100.0 %) 0 0
Erythromycin 50 (49.0 %) 0 52 (51.0 %) – – –
Levofloxacin 102 (100.0 %) 0 0 49 (100.0 %) 0 0
Moxifloxacin 102 (100.0 %) 0 0 49 (100.0 %) 0 0
Penicillin 96 (94.1 %) 6 (5.9 %) 0 – – –
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Discussion
In a study of a group of otherwise healthy children 12–
18 months of age attending immunization clinics in
Shanghai, we found a substantial number had asymptom-
atic nasopharyngeal colonization with either pneumococ-
cus (16.6 %) or Hib (8.0 %). Carriage of Haemophilus
influenzae type b in Shanghai was higher compared to
concurrent studies taking place in Dongguan and Beijing
[21, 22]. Pneumococcal carriage was lower in this study
than that in Dongguan [21], but higher than that in Beijing
[22]. The rate of pneumococcal carriage we found is
slightly lower than what has been found in the United
States (29 %) and Australia (26 %) prior to widespread
pneumococcal vaccination [23, 24], and it is much lower
than what has been found in other developing countries
before vaccination introduction; for example almost all in-
fants are colonized with pneumococcus in Papua New
Guinea and The Gambia [25]. Low carriage of these path-
ogens among persons in Shanghai may result from high
levels of antibiotic overuse [16], and Hib carriage might be
lower than pneumococcal carriage because children with
a history of PCV administration were excluded, whereas
most children in the study had received at least one dose
of Hib vaccine. There may be a substantial reduction in
carriage due to Hib vaccine coverage in the population; a
study in The Gambia found nasopharyngeal carriage de-
creased from 12 to 0.5 % after the Hib vaccine was intro-
duced [26].
It has been hypothesized that crowding, having more
children in the family, and exposure to smoking are rea-
sons why carriage is higher in developing countries than
developed countries [25]. We found an inverse associ-
ation between household size and Hib (but not pneumo-
coccal) carriage, and carriage was higher (but not
significantly so) for children with siblings compared to
single children, indicating possible effects from human
crowding. However, families in this study showed similar
characteristics to families throughout China—they had
Table 3 Odds ratios and 95 % confidence intervals for risk factors of nasopharyngeal carriage of pneumococcus or Haemophilus
influenzae type b (Hib) among 614 children in Shanghai, 2009
Pneumococcal carriage P-valuea Hib carriage P-valuea
Spring vs autumn 0.46 (0.27, 0.78) 0.0044 0.78 (0.37, 1.64) 0.5166
Age of child 0.4703 0.9533
12 months 1.46 (0.69, 3.09) 0.95 (0.34, 2.65)
13–14 months 1.34 (0.64, 2.84) 1.08 (0.39, 2.94)
15–16 months 0.94 (0.42, 2.09) 1.21 (0.43, 3.40)
17–18 months ref ref
Local vs non-local residency 0.30 (0.13, 0.69) 0.0048 0.45 (0.09, 2.32) 0.3388
Urbanicity 0.1773 0.1067
Urban 0.66 (0.34, 1.25) 0.43 (0.19, 0.97)
Suburban 1.06 (0.46, 2.44) 0.63 (0.21, 1.85)
Rural ref ref
Father’s education 0.4037 0.4163
Primary school or less 0.79 (0.21, 2.90) 8.53 (0.70, 103.52)
Junior high 1.10 (0.52, 2.34) 5.61 (0.60, 52.28)
High school/vocational 0.66 (0.29, 1.52) 5.29 (0.58, 48.43)
College or more ref ref
Household income 0.5869
<2000 yuan 2.21 (0.48, 10.18)
2000–4999 yuan 2.19 (0.47, 10.18)
≥5000 yuan ref
Size of house 0.1010
<18 m2 2.06 (0.67, 6.32)
18–29 m2 2.96 (0.99, 8.85)
30–69 m2 1.17 (0.35, 3.88)
≥70 m2 ref
≥1 dose Hib vaccine vs no doses 0.55 (0.24, 1.27) 0.1607
a P-value from Wald Chi-square test of Type 3 Analysis
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only child, and typically family members (like grandpar-
ents) take care of children during the day instead of par-
ents utilizing community daycare facilities. Accordingly,
risk factors (like large families and daycare use) common
in other places throughout the world may have a low
prevalence in China and may not be as important for de-
scribing the overall distribution of nasopharyngeal car-
riage in the population.
Approximately two-thirds of the pneumococcal iso-
lates identified are included in the current PCV-7 for-
mulation, and there is increased coverage, to about four-
fifths, with PCV-13. In contrast, the additional serotypes
in PCV-10 and PCV-15, which build upon PCV-7 and
PCV-13, respectively, do not appear to be highly preva-
lent in Shanghai children. This suggests that PCV-13 is
an appropriately comprehensive vaccine for use in
Shanghai.
Antibiotic resistance tests are important to ensure that
the clinical treatment is effective. We encountered high
resistance to erythromycin and azithromycin among
pneumococcal isolates in this study, and previous studies
have even higher levels of antibiotic resistance to
erythromycin and penicillin [27]. Antibiotic resistance in
the Hib isolates was lower than in the pneumococcal
isolates, but the relatively high resistance rate for Hib
(12.2 %) is concerning. Hib and pneumococcus can
cause a similar spectrum of invasive disease—pneumo-
nia, meningitis, or septicemia; and doctors in China
often do not identify the causative agent of disease or as-
sess for antimicrobial susceptibility before prescribing a
course of treatment. High antibiotic resistance in the
population can therefore prevent a child from receiving
an effective treatment. As Hib and pneumococcal vac-
cination coverage increases in China, sustained labora-
tory investigations of antibiotic resistance will be
necessary to ensure that the standard of care for invasive
disease is effective. Because penicillin sensitivity was still
quite high in this population, it may be the antibiotic of
choice for physicians in Shanghai treating pneumococcal
disease.
This study has several limitations. We collected speci-
mens from asymptomatic children, and, theoretically,
the pneumococcal serotypes in healthy children may dif-
fer from those with invasive pneumococcal disease.
However, previous studies in China have found some
concordance between the serotype distribution in inva-
sive and noninvasive cases [14]. We also did not test an
individual child for multiple carriage of pneumococcal
serotypes, although previous studies have found a large
proportion of children may be colonized in this manner
[28]. Additionally, our small sample size may limit our
ability to identify important risk factors for pneumococ-
cal and Hib colonization. Lastly, it is difficult to compare
the distribution of risk factors for Hib carriage to those
for pneumococcal carriage because we did not exclude
participants based on Hib vaccination, and Hib vaccine
coverage may be high enough in Shanghai to effectively
lower Hib carriage [26].
Conclusions
We found a substantial proportion of children with
asymptomatic pneumococcal and Hib colonization. In
recent years, there have been for-fee vaccines available
in China to protect against pneumococcal and Hib dis-
ease. Because carriage of these bacteria was higher in
more disadvantaged children, indicating a higher burden
of disease in these children, these vaccines may not be
reaching the children who have the highest burden of
disease. Moreover, the presence of high antibiotic sus-
ceptibility towards pneumococcus, and to a lesser extent
towards Hib, underscores the need for preventive pro-
tection against these diseases. Public funding of
pneumococcal and Hib vaccines would be one mechan-
ism to increase uptake of these vaccines.
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